Oxymap - Analysing oxygenation in treated and untreated vitreoretinopathies and oxygen related diseases in adults.

Oxymap - Analysing oxygenation in treated and untreated vitreoretinopathies and oxygen related diseases in adults. - AdultOxymap

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42158

Enrollment

Registered

2015-02-27

Start date

2015-06-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retiinal vessel dilations

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: This study will include adult patients with treated (vitreo-) retinopathies (such as M. Coats, familial exsudative vitreoretinopathy (FEVR) and retinopathy of prematurity) and oxygen-related diseases (such as amblyopia).

Exclusion criteria

Exclusion criteria: The exclusion criteria for participation are impossibility to obtain useful images for example caused by severe nystagmus, opacities of the ocular media, total retinal detachment or insufficient dilation of the pupils after administering mydriatic eye drops.

Design outcomes

Primary

Measure	Time frame
Primary outcome will be the oxygen saturation measurements of the retinal arteries and venules of the 1st and 2nd degree.	—

Secondary

Measure	Time frame
Secondary outcome will be the arterial en venular vessel diameter measurements. The increased understanding of the mechanisms of ophthalmic diseases will improve management of the disease, making earlier detection possible and increasing treatment modalities.	—

Countries

Netherlands

Outcome results